<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="23511,32460">Cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotrienes</z:chebi> are potent pro-<z:mp ids='MP_0002501'>inflammatory mediators</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="23511,32460">Cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 is one of the two <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptors cloned </plain></SENT>
<SENT sid="2" pm="."><plain>We recently reported that <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 antagonists protected against cerebral ischemic injury, and an inducible expression of <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 was found in neuron- and glial-appearing cells after traumatic injury in human brain </plain></SENT>
<SENT sid="3" pm="."><plain>To determine the role of <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 in ischemic brain injury, we investigated the temporal and spatial profile of <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 expression in rat brain from 3 h to 14 days after 30 min of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, and observed the effect of pranlukast, a <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 antagonist, on the ischemic injury </plain></SENT>
<SENT sid="4" pm="."><plain>We found that <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 mRNA expression was up-regulated in the ischemic core both 3-12 h and 7-14 days, and in the boundary zone 7-14 days after reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>In the ischemic core, <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 was primarily localized in neurons 24 h, and in macrophage/microglia 14 days after reperfusion; while in the boundary zone it was localized in proliferated astrocytes 14 days after reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>Pranlukast attenuated neurological deficits, reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and ameliorated neuron loss in the ischemic core 24 h after reperfusion; it reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, ameliorated neuron loss and inhibited astrocyte proliferation in the boundary zone 14 days after reperfusion </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, we conclude that <z:chebi fb="0" ids="23511,32460">cysteinyl</z:chebi> <z:chebi fb="0" ids="25029">leukotriene</z:chebi> receptor 1 mediates <z:hpo ids='HP_0011009'>acute</z:hpo> neuronal damage and <z:hpo ids='HP_0011011'>subacute</z:hpo>/<z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0003354'>astrogliosis</z:mp> after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>